TY  - JOUR

T1  - Phase III randomised trial of doxorubicin (A) and docetaxel (D) versus A and cyclophosphamide (C) as primary medical therapy (PMT) in women with breast cancer

JO  - Journal of Clinical Oncology

PY  - 2004/07/15

AU  - Evans TRJ

AU  - Yellowlees A

AU  - Foster E

AU  - Earl H

AU  - Cameron DA

AU  - Hutcheon AW

AU  - Coleman RE

AU  - Crown J

AU  - Leonard RC

AU  - Mansi JL

ED  - 

DO  - DOI: 10.1200/jco.2004.22.90140.521

PB  - American Society of Clinical Oncology (ASCO)

VL  - 22

IS  - 14_suppl

SP  - 521

EP  - 521

Y2  - 2025/10/10

ER  -